계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
OncoDiag
company
About
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €2.50M
- Industries
- Biotechnology,Health Care
- Founded date
- May 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
€3.10M
OncoDiag has raised a total of
€3.10M
in funding over 2 rounds. Their latest funding was raised on
Mar 15, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2021 | Series A | €2.50M | 3 | — | — | Detail |
| Dec 20, 2018 | Angel | €600K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
OncoDiag is funded by 3 investors.
SFINE
and Normandie Business Angels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SFINE
|
— | Series A |
Normandie Business Angels
|
— | Series A |
Business Angels des Grandes Ecoles
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
